Jefferies & Co. has a Buy rating and a $63 price target on shares of Teleflex TFX.
In a note sent to clients, Jefferies writes, "With pure-play status on the horizon, TFX's shares deserve an in-line multiple with competing medical device/supply competitors given its already above average FCF yield and numerous initiatives to drive incremental revenue and margin expansion."
Shares closed at $55.60 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsIndustrial ConglomeratesIndustrialsJefferies & Co.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in